Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Jean-Philippe

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|December 7, 2021
Impact of CYP2B6 genotype, tuberculosis therapy, and formulation on efavirenz pharmacokinetics in infants and children under 40 months of ageMina Nikanjam, Lana Tran, Ellen G Chadwick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2019
Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 YearsMutsa Bwakura Dangarembizi, Pearl Samson, Edmund V Capparelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2020
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of LifeKenneth Maswabi, Gbolahan Ajibola, Kara Bennett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2021
Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral SuppressionGbolahan Ajibola, Pilar Garcia-Broncano, Kenneth Maswabi, et al.
AIDS (London, England)|March 22, 2017
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infectionCarolyn Bolton Moore, Edmund V Capparelli, Pearl Samson, et al.
Journal of the International AIDS Society|June 1, 2018
Targeted HIV testing at birth supported by low and predictable mother-to-child transmission risk in BotswanaMaryanne Ibrahim, Kenneth Maswabi, Gbolahan Ajibola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2020
Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency VirusGerhard Theron, Grace Montepiedra, Lisa Aaron, et al.
AIDS (London, England)|November 27, 2018
Eliminating perinatal HIV in the United States: mission possible?Devasena Gnanashanmugam, Natella Rakhmanina, Keith W Crawford, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2023
Brief Report: Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical TrialGbolahan Ajibola, Kenneth Maswabi, Michael D Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An UpdateStephen M Graham, Luis E Cuevas, Patrick Jean-Philippe, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|December 7, 2021
Impact of CYP2B6 genotype, tuberculosis therapy, and formulation on efavirenz pharmacokinetics in infants and children under 40 months of ageMina Nikanjam, Lana Tran, Ellen G Chadwick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2019
Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 YearsMutsa Bwakura Dangarembizi, Pearl Samson, Edmund V Capparelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2020
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of LifeKenneth Maswabi, Gbolahan Ajibola, Kara Bennett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2021
Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral SuppressionGbolahan Ajibola, Pilar Garcia-Broncano, Kenneth Maswabi, et al.
AIDS (London, England)|March 22, 2017
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infectionCarolyn Bolton Moore, Edmund V Capparelli, Pearl Samson, et al.
Journal of the International AIDS Society|June 1, 2018
Targeted HIV testing at birth supported by low and predictable mother-to-child transmission risk in BotswanaMaryanne Ibrahim, Kenneth Maswabi, Gbolahan Ajibola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2020
Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency VirusGerhard Theron, Grace Montepiedra, Lisa Aaron, et al.
AIDS (London, England)|November 27, 2018
Eliminating perinatal HIV in the United States: mission possible?Devasena Gnanashanmugam, Natella Rakhmanina, Keith W Crawford, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2023
Brief Report: Long-Term Clinical, Immunologic, and Virologic Outcomes Among Early-Treated Children With HIV in Botswana: A Nonrandomized Controlled Clinical TrialGbolahan Ajibola, Kenneth Maswabi, Michael D Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An UpdateStephen M Graham, Luis E Cuevas, Patrick Jean-Philippe, et al.
Pageof 9